Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report - should the practice be changed?

Author: BouafiaF, FranchonE, GouraudA, PhamB N, RanchonF, RioufolC, SallesG, SchwiertzV, VantardN, VialT, YouB

Paper Details 
Original Abstract of the Article :
We report a case of a potential drug-drug interaction in a woman treated by a first injection of high-dose methotrexate for a T-lymphoblastic lymphoma. Valaciclovir, fluoxetine and pantoprazole were given concomitantly. A methotrexate overdosage was shown at 36 h after infusion associated with a sev...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1159/000327372

データ提供:米国国立医学図書館(NLM)

Potential Drug-Drug Interaction: A Case of Methotrexate and Proton Pump Inhibitors

This case report shines a light on a possible drug interaction between high-dose methotrexate, a powerful medication often used to combat certain cancers, and proton pump inhibitors (PPIs), commonly prescribed for heartburn. It's like mixing sand and water - while both substances are commonly found, their combination can lead to unexpected consequences. The authors report a case where a woman treated with high-dose methotrexate for lymphoma experienced severe renal failure, potentially caused by the concurrent use of a PPI. This is like trying to build a sandcastle on a beach that's about to be washed away by the tide - the combination of these drugs can be quite dangerous.

Pharmacists: The Guides in the Desert of Medication

The study highlights the importance of pharmacists in optimizing patient treatment. They can act like desert guides, carefully analyzing drug interactions and helping physicians navigate the complex landscape of medications. The study suggests discontinuing PPIs or switching to alternative medications when patients are treated with high-dose methotrexate. This is like avoiding a treacherous sandstorm by taking a different route - a small change can make a big difference in patient safety.

Navigating Medication Combinations: A Collaborative Effort

This case report underscores the importance of careful medication management, particularly when dealing with complex drug interactions. It's like trying to find your way through a maze - careful planning and communication between physicians and pharmacists are essential to ensure patient safety.

Dr. Camel's Conclusion

This case report serves as a reminder that seemingly harmless combinations of medications can have serious consequences. It emphasizes the crucial role of pharmacists in medication management, especially when dealing with potent drugs like methotrexate.

Date :
  1. Date Completed 2011-10-27
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

21597286

DOI: Digital Object Identifier

10.1159/000327372

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.